Nuvalent Drops 15% After Highly Anticipated Cancer Data — Biotech Overreaction or Red Flag?

Audio is streamed directly from the publisher (content.rss.com) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.